Dr. Jorge B Mordujovich, MD - Mount Sinai Medical Center

PDF) Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease

Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease

Find a Doctor - Mount Sinai Medical Center

Doctors Archive - Mount Sinai Medical Center

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis. - Abstract - Europe PMC

Find a Doctor - Mount Sinai Medical Center

Doctors Archive - Mount Sinai Medical Center

Clinical Research – Kidney Doctors of Miami

PDF) Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease